Dosing and Management of CRBSI in ESRF Patients

Cefazolin Dosing for CRBSI in ESRF

Cefazolin is recommended for CRBSI due to methicillin-susceptible Staphylococcus aureus (MSSA) and should replace vancomycin when susceptibility is confirmed 1
The appropriate dosage for cefazolin in hemodialysis patients is 20 mg/kg (actual body weight), rounded to the nearest 500 mg increment, administered after each dialysis session 1, 2
For patients with persistent bacteremia (>72 hours) despite appropriate therapy, a 4-6 week course of antibiotics is recommended 1

For gram-negative CRBSI in ESRF patients, ceftazidime can be used as part of empirical coverage based on local antibiogram data 1

Empirical antibiotic therapy should include vancomycin and coverage for gram-negative bacilli (such as ceftazidime) based on local antibiogram data 1, 2
If blood cultures reveal MSSA, switch from vancomycin to cefazolin 1
For gram-negative CRBSI (except Pseudomonas species), initiate appropriate antibiotics without immediate catheter removal 1

For CRBSI due to S. aureus or Pseudomonas species, catheter removal is recommended 2
For other pathogens, if symptoms resolve within 2-3 days of antibiotic therapy and there's no evidence of metastatic infection, the catheter can be exchanged over a guidewire 1
Alternatively, if symptoms resolve quickly, the catheter can be retained with adjunctive antibiotic lock therapy for 10-14 days 1

Standard CRBSI treatment duration is 10-14 days 1
For persistent bacteremia (>72 hours), endocarditis, or suppurative thrombophlebitis, extend treatment to 4-6 weeks 1
For osteomyelitis, extend treatment to 6-8 weeks 1

Infectious disease consultation is highly recommended for managing infections caused by multidrug-resistant organisms in ESRF patients 3
Surveillance blood cultures should be obtained one week after completing antibiotic therapy if the catheter has been retained 1
If follow-up blood cultures remain positive, the catheter should be removed and a new one placed after obtaining negative blood cultures 1
Antibiotic lock therapy should be used as adjunctive therapy with systemic antibiotics when attempting catheter salvage 1

Monitor for clinical improvement within 48-72 hours of initiating appropriate antibiotic therapy 1
For patients with retained catheters, obtain surveillance blood cultures one week after completing antibiotic therapy 1
If symptoms persist or worsen despite appropriate antibiotic therapy, catheter removal should be considered 1
Be vigilant for signs of metastatic infection such as endocarditis, osteomyelitis, or septic thrombophlebitis, which would require extended antibiotic courses 1